Corner Allawoona Street & Ginninderra Drive
Bruce ACT 2617
1300 742 326
Opened in 2019, our Canberra clinic resides on the campus of the University of Canberra, co-located with Ochre Health Bruce (with 23 practicing GPs). Paratus and Ochre have a history of working in partnership since 2015, fuelling the decision to start an independent clinic to allow greater volumes of research to be conducted.
Previous success in acute diseases and diagnostics can now be merged with traditional chronic disease and vaccine studies, giving more varied options to a local population who have shown considerable interest.
Paratus Clinical is located in the Belconnen district of Canberra, and shares occupancy with the University of Canberra (Building 28, next to soccer fields and across from the new sub-division of Lawson). We provide Participant onsite parking free of charge which is easily accessed.
Paratus Clinical Canberra is located within the University of Canberra and can be accessed by bus. Please use the ACT Government Journey Planner to help plan your trip.
Woden Dermatology, Level 1,
1 Bowes Place
Phillip ACT 2606
02 6282 8410
Co-located with Woden Dermatology, within close proximity to Canberra Hospital, Paratus Clinical Woden is an experienced facility with a dedicated team delivering clinical research in Dermatology, Rheumatology and Haematology.
Paratus Clinical Woden has conducted clinical research since 2011, focusing on the specialty areas of inflammatory dermatology including psoriasis, atopic dermatitis, acne, and skin cancers. In recent years, scope has widened to support innovative Haematology and Rheumatology research.
There is paid parking available outside the clinic, alternatively you can park at the Westfields or Neptune parking at Woden.
There is a bus interchange located directly outside the clinic on Callam Street within walking distance. Please use the ACT Government Journey Planner to help plan your trip.
Featured clinical trials
Now recruiting at this location
A Phase 3 Clinical Study to Evaluate the Safety and Immunogenicity of Experimental Pneumococcal Vaccine.
This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.
Our Canberra Team
Dr. Amber Leah
Dr. Diana Rubel
A/Prof Dr. Dipti Talaulikar
Dr. Anna Raj
Dr. Gina Tsai
Dr. Hong Jie Soh
Are you interested in participating in clinical trials?
We value your privacy and are committed to protecting your data and personal information.